The DEA extended telemedicine prescribing flexibilities for controlled substances through the end of 2026, drawing praise from telehealth advocates who are urging a permanent solution.
The post Advocates Applaud DEA’s Fourth Extension of Remote Prescribing Flexibilities appeared first on MedCity News.
